Harvard Bioscience (HBIO) Cash from Operations (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Cash from Operations of 662000.0 for Q1 2026, down 122.17% year-over-year from 2986000.0 in Q1 2025, and down 589.58% quarter-over-quarter from 96000.0 in Q4 2025.
Harvard Bioscience (HBIO) Cash from Operations (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Cash from Operations for 17 consecutive years, with 662000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 122.17% year-over-year to 662000.0; the TTM figure through Mar 2026 stood at 3081000.0 (up 1.92% YoY), while the FY2025 annual figure was 6729000.0, up 367.29% from the prior year.
- Cash from Operations declined to 662000.0 in Q1 2026 per HBIO's latest filing, from 96000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 4361000.0 in Q3 2023 and bottomed at 1986000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 1334529.41 across 5 years, with a median of 1403000.0 in 2024.
- On a YoY basis, Cash from Operations climbed as much as 2189.74% in 2022 and fell as far as 291.51% in 2022.
- Harvard Bioscience's Cash from Operations stood at 2679000.0 in 2022, then surged by 60.62% to 4303000.0 in 2023, then slumped by 59.91% to 1725000.0 in 2024, then slumped by 105.57% to 96000.0 in 2025, then plunged by 589.58% to 662000.0 in 2026.
- Business Quant data shows HBIO's Cash from Operations at 662000.0 in Q1 2026, 96000.0 in Q4 2025, and 1084000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.06 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 776.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 454.63 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 715.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 124.00 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 227.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 182.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 297.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 325,000.00 |
| Jun 30, 2026 | 325,000.00 |
| Mar 31, 2026 | -662,000.00 |
| Mar 31, 2026 | -662,000.00 |
| Dec 31, 2025 | -96,000.00 |
| Dec 31, 2025 | -96,000.00 |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | -842,000.00 |
| Sep 30, 2024 | -842,000.00 |
| Jun 30, 2024 | -846,000.00 |
| Jun 30, 2024 | -846,000.00 |
| Mar 31, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.40 Mn |